Clinical Trial Update: Phase II Clinical Study of Contezolid for the Treatment of Tuberculous Meningitis [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase I/II clinical trial of contezolid for tuberculous meningitis is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis
• Tuberculous Meningitis

Drugs mentioned

• Contezolid (contezolid)

Snippet

Sponsor: Beijing Chest Hospital | Conditions: Tuberculosis, Meningitis | Phase 1, Phase 2 | Status: ENROLLING_BY_INVITATION